Drawing for GENENET

USPTO serial 87057888

GENENET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HALMEN, KATHERINE E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENENET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiologyACTIVE—
005Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposesACTIVE—
042Biological research; Biomedical research services; DNA analysis services for scientific research purposes; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of genetics; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Research and development of new products; Research on the subject of pharmaceuticals; Scientific laboratory services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development and consultation related thereto in the field of genetics; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of technology in the field of genetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccinesACTIVE—
044Health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing for diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 24, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 24, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 20, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 25, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2016DOCKASSIGNED TO EXAMINER—
Jun 10, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jun 9, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 6, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance